Screening and identification of key genes in imatinib-resistant chronic myelogenous leukemia cells: a bioinformatics study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Screening and identification of key genes in imatinib-resistant chronic myelogenous leukemia cells: a bioinformatics study

Published:2021-01-01 Issue:1 Volume:26 Page:408-414
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Zhang Hong¹,Wang Peiran²,Song Ting²,Bonnette Uwituze Laura¹,Zhang Zhichao¹

Affiliation:

1. State Key Laboratory of Fine Chemicals, School of Life Science and Technology, Dalian University of Technology, Dalian, People’s Republic of China

2. State Key Laboratory of Fine Chemicals, School of Chemistry, Dalian University of Technology, Dalian, People’s Republic of China

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1931740

Reference57 articles.

1. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

2. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

3. Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia

4. High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia

5. Gene expression signatures associated with the resistance to imatinib

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatic analysis of the expression profile and identification of RhoGDI2 as a biomarker in imatinib-resistant K562 cells;Hematology;2023-08-18

2. High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia;Translational Cancer Research;2023-04

3. Identification and Validation of Afatinib Potential Drug Resistance Gene BIRC5 in Non-Small Cell Lung Cancer;Frontiers in Oncology;2021-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3